Thelansis: Market Research Reports

The Team

Thelansis is the brain-child of specialized experts with multiple years of experience in healthcare management consulting.
Our core team is comprised of esteemed professionals, including reputed physicians, business analysts, and biotechnologists.
Thelansis combines global expertise and insight, with a rich mix of scientific and business development backgrounds.
We are guided by a strong set of values, including a commitment to professional diversity.

The Target

Our team strives to provide organizations with exceptional market research that will inform strategic business decisions.
We partner with organizations to help support their vision, and maintain a reputation as a Valued Knowledge Partner.

Publications found: 321

Sort by:

Fallopian Tube Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Fallopian Tube Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

June 2017 145 pages

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino De Andrade'S Disease) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)' - Market Access, Reimbursement Outlook, Competitive Landscapet, ...

June 2017 180 pages

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology ... better diagnosis of biomarkers. Key patient segment and market based on type, severity and stages of the disease. Disease burden, compliance ...

June 2017 215 pages

Gastritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Gastritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

June 2017 184 pages

Gastrointestinal Stromal Tumor (Gist) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Gastrointestinal Stromal Tumor (GIST)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

June 2017 205 pages

Gastroparesis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Gastroparesis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

June 2017 156 pages

Gastric Ulcers - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Gastric Ulcers' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 184 pages

Hairy Cell Leukemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hairy Cell Leukemia' - Market Access, Reimbursement Outlook ... launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, ... , Mortality 11 years of epidemiology and market projections Incidence/ Prevalence patient population Mortality, ...

June 2017 150 pages

Gouty Arthritis (Gout) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Gouty Arthritis (Gout)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

June 2017 158 pages

Alpha- Antitrypsin Deficiency - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Alpha- Antitrypsin Deficiency' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

June 2017 161 pages

Chemotherapy Induced Neutropenia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chemotherapy Induced Neutropenia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

June 2017 212 pages

Actinic Keratosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Actinic Keratosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 172 pages

Narcolepsy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Narcolepsy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

June 2017 204 pages

Urinary Incontinence - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Urinary Incontinence' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 167 pages

Diabetic Retinopathy - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Diabetic retinopathy' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 179 pages

Cushing'S Syndrome - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Cushing's Syndrome' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 171 pages

Endometriosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Endometriosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

June 2017 153 pages

Eosinophilic Esophagitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Eosinophilic Esophagitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 135 pages

Graft Versus Host Disease (Gvhd) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

... 'Graft versus host disease (GVHD)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease ... market based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy, reimbursement ...

June 2017 168 pages

Cervical Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Cervical Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

June 2017 216 pages

Behcet'S Disease - Market Outlook, Market Forecast And Competitve Landscape Report - 2018 To 2030

US$ 5,000.00

... Knowledge Partners 'Behcet's Disease' - Market Outlook, Market Forecast and Competitive Landscapet report – 2018 to 2030' report comprises of the Disease overview, classifications, ... and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base ...

March 2017 211 pages

Bacterial Conjunctivitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Bacterial Conjunctivitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 203 pages

Bacterial Pneumonia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Bacterial Pneumonia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 207 pages

Bacterial Vaginosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Bacterial Vaginosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 183 pages

Basal Cell Carcinoma (Basal Cell Epithelioma) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Basal Cell Carcinoma (Basal Cell Epithelioma)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ...

March 2017 145 pages

B-Cell Chronic Lymphocytic Leukemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'B-Cell Chronic Lymphocytic Leukemia - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2017 201 pages

B-Cell Lymphomas - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'B-Cell Lymphomas' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 153 pages

Biliary Tumor - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Biliary Tumor' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 204 pages

Bipolar Disorder (Manic Depression) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Bipolar Disorder (Manic Depression)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2017 187 pages

Blepharitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Blepharitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 211 pages

Bone Metastasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Bone Metastasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 148 pages

Candidiasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Candidiasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 157 pages

Chemotherapy Induced Anemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chemotherapy Induced Anemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

March 2017 185 pages

Choroidal Neovascularization - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Choroidal Neovascularization' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 174 pages

Chronic Bronchitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chronic Bronchitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 146 pages

Chronic Hand Eczema - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chronic Hand Eczema' - Market Access, Reimbursement Outlook ... launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, ... , Mortality 11 years of epidemiology and market projections Incidence/ Prevalence patient population Mortality, ...

March 2017 173 pages

Chronic Heart Failure - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chronic Heart Failure' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2017 172 pages

Chronic Inflammatory Demyelinating Polyneuropathy (Cidp) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

March 2017 202 pages

Chronic Kidney Disease (Chronic Renal Failure) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

... Chronic Kidney Disease (Chronic Renal Failure)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease ... based on type, severity and stages of the disease. Disease burden, compliance rate, annual cost of therapy, ...

March 2017 201 pages

Chronic Liver Disease - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

... 'Chronic Liver Disease' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease ... biomarkers. Key patient segment and market based on type, severity and stages of the disease. Disease burden, compliance rate, annual ...

March 2017 169 pages

Chronic Plaque Psoriasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Chronic Plaque Psoriasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

March 2017 203 pages

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Clostridium Difficile Infections (Clostridium Difficile Associated Disease)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology ...

March 2017 209 pages

Condyloma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Condyloma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 202 pages

Cystitis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Cystitis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 210 pages

Dyskinesia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Dyskinesia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 175 pages

Dyspepsia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Dyspepsia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 156 pages

Hereditary Angioedema - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Hereditary Angioedema' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 211 pages

Von Willebrand Disease - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

... 'Von Willebrand Disease' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – 2015 to 2030' report comprises of the Disease ... biomarkers. Key patient segment and market based on type, severity and stages of the disease. Disease burden, compliance rate, annual ...

March 2017 219 pages

Waldenstrom Macroglobulinemia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Waldenstrom Macroglobulinemia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

March 2017 204 pages

Xerostomia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Xerostomia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

March 2017 180 pages